Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in ALEC — Alector, Inc.

CIK 916542 Boston, MA
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,872,833
+$189,446 QoQ
Shares Held
4,414,345
+9.3% QoQ
Ownership
3.95%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 140 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. ALEC ranks #18 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in ALEC

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,872,833 4,414,345
2026-03-31 $8,683,387 4,038,785
2025-12-31 $5,370,220 3,442,449
2025-09-30 $7,024,035 2,372,985
2025-06-30 $3,038,543 2,170,388
2025-03-31 $1,772,013 1,440,661
2024-12-31 $1,947,561 1,030,456
2024-09-30 $3,449,495 740,235
2024-06-30 $2,681,605 590,662
2024-03-31 $2,676,774 444,647
2023-12-31 $1,138,833 142,711
2023-09-30 $993,163 153,266
2023-06-30 $547,577 91,111
2023-03-31 $62,890 10,160
2022-12-31 $947,117 102,613
2022-09-30 $1,723,905 182,231
2022-06-30 $985,286 96,977
2022-03-31 $479,583 33,655
2021-12-31 $845,555 40,947